Skip to content

Clinical trials

Cardiomyopathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: United States Clear all

230 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20024
20035
20046
20057
20069
20079
200810
20096
201010
20113
20129
20135
201417
201512
201614
20174
201811
20197
20207
202110
202215
20238
202411
202511
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed121
Recruiting45
Terminated18
Unknown status15
Active, not recruiting10
Withdrawn9
Enrolling by invitation6
Not yet recruiting3
Suspended2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic10
Alnylam Pharmaceuticals9
Emory University7
Abbott Medical Devices6
Lexeo Therapeutics6
National Heart, Lung, and Blood Institute (NHLBI)6
Pfizer5
Stanford University5
University of Pittsburgh5
Eidos Therapeutics, a BridgeBio company4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies230
Heart Failure92
Heart Diseases22
Amyloidosis21
Cardiovascular Diseases19
Arrhythmias, Cardiac16
Death, Sudden, Cardiac15
Cardiomyopathy, Hypertrophic11
Myocardial Infarction10
Muscular Dystrophy, Duchenne9

Trials

Showing 1 to 25 of 230. Each trial links to its page on Pharma Observatory.

130 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.